Literature DB >> 28750234

Identification of a novel component leading to anti-tumor activity besides the major ingredient cordycepin in Cordyceps militaris extract.

Takeharu Wada1, I Wayan Sumardika2, Shingo Saito3, I Made Winarsa Ruma2, Eisaku Kondo4, Masami Shibukawa3, Masakiyo Sakaguchi5.   

Abstract

In accordance with our previous study that was carried out to identify novel anti-tumor ingredients, chromatographic separation in combination with an anti-tumor activity assay was used for analysis of Cordyceps militaris extract in this study. Various modes of chromatography including reversed-phase, cation-exchange and anion-exchange were used to separate components of Cordyceps militaris, which showed various chemical properties. Anti-tumor activity of each fraction was assessed by a Hoechst staining-based apoptosis assay using malignant melanoma MeWo cells. By these repeated approaches through chromatographic segregation and cell biological assay, we finally succeeded in identifying the target substance from a certain fraction that included neutral hydrophilic components using a pre-column and post-column chlorine adduct ionization LC-APCI-MS method. The target substance was a mono-carbohydrate, xylitol, that induced apoptotic cell death in MeWo cells but not in normal human OUMS-24 fibroblasts. This is the first study showing that Cordyceps militaris extract contains a large amount of xylitol. Thus, our results will contribute greatly to uncovering the mysterious multifunctional herbal drug Cordyceps militaris as an anti-tumor agent.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-tumor; Cordyceps militaris; Liquid chromatography mass spectrometry; Melanoma; Solid phase extraction; Xylitol

Mesh:

Substances:

Year:  2017        PMID: 28750234     DOI: 10.1016/j.jchromb.2017.07.022

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  6 in total

1.  Partial Substitution of Glucose with Xylitol Prolongs Survival and Suppresses Cell Proliferation and Glycolysis of Mice Bearing Orthotopic Xenograft of Oral Cancer.

Authors:  Yuraporn Sahasakul; Wannee Angkhasirisap; Aroonwan Lam-Ubol; Amornrat Aursalung; Daisuke Sano; Kentaro Takada; Dunyaporn Trachootham
Journal:  Nutrients       Date:  2022-05-11       Impact factor: 6.706

2.  Tussah silkmoth pupae improve anti-tumor properties of Cordyceps militaris (L.) Link by increasing the levels of major metabolite cordycepin.

Authors:  Zhixin Wen; Xingfan Du; Nan Meng; Yajie Li; Rui Mi; Xuejun Li; Yongxin Sun; Shuhui Ma; Shuying Li
Journal:  RSC Adv       Date:  2019-02-13       Impact factor: 4.036

3.  Xanthine Oxidase Inhibitory Potential, Antioxidant and Antibacterial Activities of Cordyceps militaris (L.) Link Fruiting Body.

Authors:  Tran Ngoc Quy; Tran Dang Xuan
Journal:  Medicines (Basel)       Date:  2019-01-29

4.  Se-Enriched Cordyceps militaris Inhibits Cell Proliferation, Induces Cell Apoptosis, And Causes G2/M Phase Arrest In Human Non-Small Cell Lung Cancer Cells.

Authors:  Lihua Luo; Ruizhi Ran; Jie Yao; Fang Zhang; Maohui Xing; Min Jin; Lanqing Wang; Tao Zhang
Journal:  Onco Targets Ther       Date:  2019-10-23       Impact factor: 4.147

5.  Polyphenol Extract from "Greco" Grape Canes: Characterization, Antioxidant Capacity, and Antitumor Effects on Cal-33 and JHU-SCC-011 Head and Neck Squamous Cell Carcinoma.

Authors:  Giuseppe Squillaci; Francesca Vitiello; Laura Mosca; Francesco La Cara; Giovanna Cacciapuoti; Marina Porcelli; Alessandra Morana
Journal:  Molecules       Date:  2022-04-15       Impact factor: 4.927

6.  Antileukaemic Cell Proliferation and Cytotoxic Activity of Edible Golden Cordyceps (Cordyceps militaris) Extracts.

Authors:  Singkome Tima; Tawat Tapingkae; Chaiwat To-Anun; Parinn Noireung; Phikul Intaparn; Wantida Chaiyana; Jakkapan Sirithunyalug; Pawaret Panyajai; Natsima Viriyaadhammaa; Wariya Nirachonkul; Lapamas Rueankham; Win Lae Aung; Fah Chueahongthong; Sawitree Chiampanichayakul; Songyot Anuchapreeda
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-22       Impact factor: 2.650

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.